{
  "Variants Include": [
    {
      "Gene": "PARK7",
      "variants": [
        {
          "HGVS": "NM_001126112.3:c.77G>A",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "G",
            "alt": "A",
            "position": "77"
          },
          "Protein Change": {
            "ref": "M",
            "alt": "I",
            "position": "26"
          },
          "Description in input context": "M26I"
        },
        {
          "HGVS": "NM_001126112.3:c.497G>A",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "G",
            "alt": "A",
            "position": "497"
          },
          "Protein Change": {
            "ref": "L",
            "alt": "P",
            "position": "166"
          },
          "Description in input context": "L166P"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005260"
  },
  "Experiment Method": [
    {
      "Assay Method": "Yeast two-hybrid screening",
      "Material used": {
        "Material Source": "Human fetal brain library",
        "Material Name": "PARK7/DJ-1 interactors",
        "Description": "Yeast two-hybrid screening was performed using a human fetal brain library to identify interactors of PARK7/DJ-1."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.77G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Enhanced binding affinity",
          "Result Description": "The M26I variant exhibited stronger interaction with TTRAP compared to wild-type PARK7."
        },
        {
          "Variant": "NM_001126112.3:c.497G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Enhanced binding affinity",
          "Result Description": "The L166P variant exhibited stronger interaction with TTRAP compared to wild-type PARK7."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly described in the text."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly described in the text."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not explicitly described in the text."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not explicitly described in the text."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "No specific threshold described in the text.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "No specific threshold described in the text.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Apoptosis assay in neuroblastoma cells",
      "Material used": {
        "Material Source": "Cell culture",
        "Material Name": "Neuroblastoma cells",
        "Description": "Apoptosis was assessed in neuroblastoma cells treated with proteasome inhibitors and exposed to PARK7/DJ-1 variants."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.77G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Loss-of-function",
          "Result Description": "The M26I variant significantly increased apoptosis compared to wild-type PARK7."
        },
        {
          "Variant": "NM_001126112.3:c.497G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Loss-of-function",
          "Result Description": "The L166P variant significantly increased apoptosis compared to wild-type PARK7."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly described in the text."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly described in the text."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not explicitly described in the text."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not explicitly described in the text."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "No specific threshold described in the text.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "No specific threshold described in the text.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}